PHD3 Antibody [H19K23] | Primary Antibodies

Application: Reactivity: Mouse, Rat, Human

Lane 1: RAW 264.7, Lane 2: PC-12, Lane 3: Mouse brain, Lane 4: Rat brain

Usage Information

Dilution
WB1:2000 IP1:70 IF1:250

Application
WB, IP, IF

Reactivity
Mouse, Rat, Human

Source
Rabbit Monoclonal Antibody

Storage Buffer
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage (from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years

Predicted MW Observed MW
27 kDa 27 kDa
^*Why do the predicted and actual molecular weights differ? The following reasons may explain differences between the predicted and actual protein molecular weight. Post-translational modifications(e.g., phosphorylation, glycosylation); Splice variants and isoforms; Relative charge; Multimerization.

Datasheet & SDS

Biological Description

Specificity
PHD3 Antibody [H19K23] detects endogenous levels of total PHD3 protein.

Clone
H19K23

Synonym(s)
Prolyl hydroxylase EGLN3; Egl nine homolog 3; HPH-1; Hypoxia-inducible factor prolyl hydroxylase 3; Prolyl hydroxylase domain-containing protein 3; HIF-PH3; HIF-prolyl hydroxylase 3; HPH-3; PHD3; EGLN3

Background
Prolyl hydroxylase domain‑containing protein 3 (PHD3; EGLN3) is an Fe²⁺‑ and 2‑oxoglutarate‑dependent dioxygenase that functions as a cellular oxygen sensor by hydroxylating proline residues on hypoxia‑inducible transcription factors HIF‑1α and HIF‑2α and thereby targeting them for von Hippel–Lindau–mediated ubiquitination and proteasomal degradation under normoxic conditions. PHD3 is widely expressed in oxygen‑sensitive tissues such as the heart, brain, and skeletal muscle, and its transcription is induced by both HIF‑1α and HIF‑2α, creating a feedback loop that couples oxygen availability to the stability and activity of HIF‑dependent transcription programs. Under hypoxia, reduced PHD3 activity allows HIF‑1α and HIF‑2α to accumulate, bind hypoxia‑responsive elements, and drive the expression of genes involved in erythropoiesis, angiogenesis, and metabolic adaptation, whereas PHD3‑dependent hydroxylation restrains this program when oxygen returns. PHD3 can act as a nuclear cofactor for HIF‑1α, enhancing HIF‑1α‑driven transcription at specific target promoters, and PHD3 expression modulates EGFR phosphorylation and downstream mitogenic signaling in certain tumor types. Loss or downregulation of PHD3 enables tumor cells to grow in hypoxic microenvironments by stabilizing HIF‑dependent pathways and by providing an alternative route of EGFR activation, promoting tumor expansion and resistance to hypoxia‑associated stress. Depletion of PHD3 reduces cardiomyocyte apoptosis and infarct size after ischemia–reperfusion, and loss of PHD3 in myeloid cells dampens inflammatory activation in injured skeletal muscle.

Background

Prolyl hydroxylase domain‑containing protein 3 (PHD3; EGLN3) is an Fe²⁺‑ and 2‑oxoglutarate‑dependent dioxygenase that functions as a cellular oxygen sensor by hydroxylating proline residues on hypoxia‑inducible transcription factors HIF‑1α and HIF‑2α and thereby targeting them for von Hippel–Lindau–mediated ubiquitination and proteasomal degradation under normoxic conditions. PHD3 is widely expressed in oxygen‑sensitive tissues such as the heart, brain, and skeletal muscle, and its transcription is induced by both HIF‑1α and HIF‑2α, creating a feedback loop that couples oxygen availability to the stability and activity of HIF‑dependent transcription programs. Under hypoxia, reduced PHD3 activity allows HIF‑1α and HIF‑2α to accumulate, bind hypoxia‑responsive elements, and drive the expression of genes involved in erythropoiesis, angiogenesis, and metabolic adaptation, whereas PHD3‑dependent hydroxylation restrains this program when oxygen returns. PHD3 can act as a nuclear cofactor for HIF‑1α, enhancing HIF‑1α‑driven transcription at specific target promoters, and PHD3 expression modulates EGFR phosphorylation and downstream mitogenic signaling in certain tumor types. Loss or downregulation of PHD3 enables tumor cells to grow in hypoxic microenvironments by stabilizing HIF‑dependent pathways and by providing an alternative route of EGFR activation, promoting tumor expansion and resistance to hypoxia‑associated stress. Depletion of PHD3 reduces cardiomyocyte apoptosis and infarct size after ischemia–reperfusion, and loss of PHD3 in myeloid cells dampens inflammatory activation in injured skeletal muscle.

References
https://pubmed.ncbi.nlm.nih.gov/28796258/ https://pubmed.ncbi.nlm.nih.gov/25633836/

Reference Table for Selecting PVDF Membrane Pore Size Specifications

Protein Size (kDa)	PVDF Transfer Membrane Pore Size (μm)
< 10	0.22
10-20	0.22
20-30	0.45
30-45	0.45
45-70	0.45
80-100	0.45
100-140	0.45
> 140	0.45

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Protein Size (kDa)	Separating Gel Percentage
4-40	20%
12-45	15%
10-70	12.5%
15-100	10%
25-100	8%
60-210	5%